LECAP Asset Management’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$629K Buy
+5,458
New +$587K 0.3% 142

Other funds holding CORT

LECAP Asset Management's CORT Position: Q3 2026 in Review

LECAP Asset Management opened a new position in Corcept Therapeutics (CORT) in Q3 2026: 5,458 shares worth $629K. The stake represents 0.3% of the portfolio and ranks #142 among its holdings.

503 funds tracked by Wall St. Rank hold CORT as of Q3 2026.

  • LECAP Asset Management held 5,458 shares of Corcept Therapeutics worth $629K as of Q3 2026.
  • Corcept Therapeutics was a new LECAP Asset Management position in Q3 2026.
  • Corcept Therapeutics made up 0.3% of LECAP Asset Management's portfolio in Q3 2026, its #142 holding.
  • 503 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2026.

Based on LECAP Asset Management's 13F filing for Q3 2026, filed 27 Oct 2026.